Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in healthy Chinese women from Hong Kong. - Concepedia

Concepedia

Publication | Closed Access

Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in healthy Chinese women from Hong Kong.

31

Citations

15

References

2010

Year

K. F. Tam, Karen K. L. Chan, Haïwen Tang, Dan Bi, Dominique Descamps, Hans L. Bock

Abstract

The human papillomavirus-16/18 AS04-adjuvanted vaccine was highly immunogenic, safe, and generally well tolerated in Chinese women from Hong Kong.

References

	Year	Citations

Page 1